U.S., June 27 -- ClinicalTrials.gov registry received information related to the study (NCT07040085) titled 'Y-6 Sublingual Tablets for Patients With Acute Ischemic Stroke' on June 10.
Brief Summary: This study aims to evaluate the efficacy of Y-6 sublingual tablets in improving microcirculation dysfunction and reducing thrombo-inflammation in patients who had AIS caused by LVO and will receive EVT. Moreover, we expect to evaluate the safety of using Y-6 sublingual tablet in such study population.
This study rationale is based on the following scheme: in patients with acute ischemic stroke caused by LVO, receiving reperfusion therapy may cause futile recanalization and thus lead to microcirculation dysfunction and thrombo-inflammation as ...